Lorence M C, Corbin C J, Kamimura N, Mahendroo M S, Mason J I
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas 75235-9051.
Mol Endocrinol. 1990 Dec;4(12):1850-5. doi: 10.1210/mend-4-12-1850.
The structural gene encoding human 3 beta-hydroxysteroid dehydrogenase/delta 5----4-isomerase (3 beta HSD) was isolated from a human EMBL3 genomic library. The gene encompasses approximately 8 kilobases of DNA and is comprised of two large introns and three exons encoding amino acid residues 1-48, 49-103, and 104-373, respectively. The exonic sequence is identical to that of the cDNA that we previously isolated and expressed in COS 1 cells. DNA sequence analysis reveals a putative TATA (TATATAA) motif 26 basepairs up-stream of the beginning of exon I, as determined by S1 nuclease protection analysis. However, primer extension analysis using poly(A)+ RNA isolated from both placenta and corpora lutea indicates that the RNA initiates up-stream of the putative TATA motif, and that an additional 53-basepair exon, which is untranslated, is present 5' to the first coding exon. Southern hybridization analysis of genomic DNA using a single exon probe suggests that there may be more than one copy of the gene in the human genome. In addition, we confirm from Southern analysis of genomic DNA isolated from human x hamster somatic cell hybrids that the gene is located on human chromosome 1. These findings will provide a foundation for the characterization of apparent 3 beta HSD clinical deficiencies when these are due to a mutation in the structural gene.
编码人 3β-羟基类固醇脱氢酶/δ5→4-异构酶(3βHSD)的结构基因是从人 EMBL3 基因组文库中分离出来的。该基因包含约 8 千碱基的 DNA,由两个大的内含子和三个外显子组成,分别编码氨基酸残基 1 - 48、49 - 103 和 104 - 373。外显子序列与我们先前分离并在 COS 1 细胞中表达的 cDNA 序列相同。DNA 序列分析显示,通过 S1 核酸酶保护分析确定,在外显子 I 起始位点上游 26 个碱基对处有一个假定的 TATA(TATATAA)基序。然而,使用从胎盘和黄体中分离的 poly(A)+ RNA 进行的引物延伸分析表明,RNA 起始于假定的 TATA 基序上游,并且在第一个编码外显子的 5' 端存在一个额外的 53 个碱基对的未翻译外显子。使用单个外显子探针进行的基因组 DNA Southern 杂交分析表明,人类基因组中该基因可能有多个拷贝。此外,我们通过对从人×仓鼠体细胞杂种中分离的基因组 DNA 进行 Southern 分析证实,该基因位于人类染色体 1 上。这些发现将为表征因结构基因突变导致的明显 3βHSD 临床缺陷奠定基础。